Kilter Group’s CONMED CNMD Stock Holding History

Kilter Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.31K	Buy	101 +38	+60%	+$1.37K	﹤0.01%	828
2026 Q1	$2.23K	Buy	63 +19	+43%	+$773	﹤0.01%	908
2025 Q4	$1.79K	Buy	+44	New	+$1.91K	﹤0.01%	843

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Kilter Group's CNMD Position: Q2 2026 in Review

Kilter Group increased its CONMED (CNMD) stake by 60% in Q2 2026, buying an estimated $1.37K and bringing the position to 101 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #828.

Kilter Group first reported a position in CNMD in Q4 2025 and has held it in 3 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Kilter Group held 101 shares of CONMED worth $3.31K as of Q2 2026.
Kilter Group bought 38 CONMED shares in Q2 2026, an estimated $1.37K.
CONMED made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #828 holding.
Kilter Group first reported a position in CONMED in Q4 2025 and has held it in 3 quarters since.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.